Comments from Speaker
The overall grant rate in Japan is higher than other jurisdictions． One of the reasons is that it is easy to overcome inventive step rejections.
However, in some cases, we do indeed face difficulties. Here in this presentation, we will focus on biotech/pharmaceutical inventions and provide tips to overcome the potential inventive step hurdle.
Note
- The webinar is expected to consist of a 20 to 30-minute presentation and a 5 to 10-minute Q&A session.
- If you miss watching the live session, you will receive an on-demand recorded video link a day after the live session is over. Please still register with the registration form below.
- This webinar is aimed at providing IP information to our business partners and clients from overseas. Registration from persons who work for IP firms or law firms in Japan will not be approved as this may be deemed as a conflict of interest with our business.